Eascra Biotech

About

Eascra Biotech is advancing the next generation of targeted cancer treatments through the development of Janus base nanomaterials (JBNs). They are advancing two commercial cancer therapies: a JBN‑based chemotherapy and a JBN‑based immunotherapy designed to precisely target solid tumors.